54 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
delivery dates, quality, quantity and pricing of raw materials, including due to the COVID-19 pandemic, which may result in additional costs and delays … .
Other General Risks
Apexigen faces risks related to health epidemics and other outbreaks, such as the COVID-19 pandemic, which could adversely impact
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
, (ii) effects of natural disasters, pandemic outbreaks, hostility, terrorist activity, cyberattacks or declaration or escalation of war or act of public … ” shall mean SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks.
“COVID-19
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
) effects of natural disasters, pandemic outbreaks, hostility, terrorist activity, cyberattacks or declaration or escalation of war or act of public … mean SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks.
“COVID-19
424B3
okorgzwmno9u0jsb9
10 Apr 23
Prospectus supplement
4:03pm
424B3
5130fw90pxe6
10 Apr 23
Prospectus supplement
4:02pm
POS AM
vqys40dxkonk121txh0b
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
e8j9rebh88 ywuzse2
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
z55wy
9 Sep 22
Prospectus supplement
4:40pm
424B3
rmzroxa c3n
9 Sep 22
Prospectus supplement
4:38pm
8-K/A
EX-99.2
y798ozxir brni7p05
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K/A
EX-99.1
pcsgol 3o7qi7ehs2
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm